Who is sponsoring NCT05307016?

NCT05307016 is sponsored by Sohag University.

What drugs are being tested in NCT05307016?

Interventions in NCT05307016: Two dimensional ultrasonography power and color doppler.

What condition does NCT05307016 study?

NCT05307016 studies Morbidly Adherent Placenta.

Is NCT05307016 still recruiting?

NCT05307016 is currently status unknown. Last updated 1 April 2022.

Last reviewed 2022-04-01 · How we verify

NCT05307016

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Morbidly Adherent Placenta, Diagnosis and Proper Management

Status unknown Last updated 1 April 2022

What this trial tests

trial testing Two dimensional ultrasonography power and color doppler in Morbidly Adherent Placenta in 100 participants. Status unknown.

Timeline

1 February 2022

Primary endpoint
1 February 2023

1 May 2023

Quick facts

Lead sponsor	Sohag University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 February 2022
Primary completion	1 February 2023
Estimated completion	1 May 2023
Sites	1 location across Egypt

Drugs / interventions tested

Two dimensional ultrasonography power and color doppler

Conditions studied

Morbidly Adherent Placenta — all drugs for Morbidly Adherent Placenta →

Sponsor

Sohag University

Who can join

Eligibility, female only, with Morbidly Adherent Placenta. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main idea of this study is to establish the diagnostic criteria for cases of morbidly adherent placenta (MAP) using different ultrasonographic modalities and compare this with intra-operative findings and postoperative histopathological assessment

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05307016 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 1 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05307016.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing